Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 22% ± 6% | |
endothelial cell | 3 studies | 21% ± 3% | |
epithelial cell | 3 studies | 23% ± 6% | |
GABAergic neuron | 3 studies | 33% ± 3% | |
glutamatergic neuron | 3 studies | 42% ± 7% | |
oligodendrocyte | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2246.12 | 1445 / 1445 | 100% | 25.33 | 183 / 183 |
prostate | 100% | 2665.10 | 245 / 245 | 100% | 24.69 | 502 / 502 |
skin | 100% | 2906.49 | 1809 / 1809 | 100% | 29.61 | 472 / 472 |
lung | 100% | 2997.68 | 578 / 578 | 100% | 24.19 | 1154 / 1155 |
breast | 100% | 2147.25 | 459 / 459 | 100% | 23.40 | 1117 / 1118 |
ovary | 100% | 2441.27 | 180 / 180 | 100% | 25.12 | 429 / 430 |
stomach | 100% | 2270.38 | 359 / 359 | 100% | 19.87 | 285 / 286 |
intestine | 100% | 2406.72 | 966 / 966 | 100% | 20.95 | 525 / 527 |
bladder | 100% | 2001.95 | 21 / 21 | 100% | 19.97 | 502 / 504 |
uterus | 100% | 2385.81 | 170 / 170 | 100% | 21.59 | 457 / 459 |
thymus | 100% | 3885.72 | 653 / 653 | 100% | 24.86 | 602 / 605 |
brain | 100% | 2380.32 | 2632 / 2642 | 100% | 24.59 | 703 / 705 |
pancreas | 100% | 1763.47 | 327 / 328 | 99% | 20.19 | 177 / 178 |
kidney | 100% | 2773.17 | 89 / 89 | 99% | 18.26 | 889 / 901 |
adrenal gland | 100% | 2704.28 | 258 / 258 | 97% | 18.30 | 224 / 230 |
liver | 100% | 1421.69 | 226 / 226 | 91% | 9.61 | 369 / 406 |
adipose | 100% | 2053.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.24 | 29 / 29 |
spleen | 100% | 3502.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.76 | 1 / 1 |
blood vessel | 100% | 1978.26 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1926.99 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3809.95 | 920 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 23.13 | 79 / 80 |
heart | 98% | 1692.49 | 848 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_1990390 | Biological process | protein K33-linked ubiquitination |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AREL1 |
Protein name | Apoptosis resistant E3 ubiquitin protein ligase 1 Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1) HECT-type E3 ubiquitin transferase (EC 2.3.2.26) |
Synonyms | KIAA0317 |
Description | FUNCTION: E3 ubiquitin-protein ligase that catalyzes 'Lys-11'- or 'Lys-33'-linked polyubiquitin chains, with some preference for 'Lys-33' linkages . E3 ubiquitin-protein ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates . Ubiquitinates SEPTIN4, DIABLO/SMAC and HTRA2 in vitro . Modulates pulmonary inflammation by targeting SOCS2 for ubiquitination and subsequent degradation by the proteasome . . |
Accessions | O15033 ENST00000481010.6 ENST00000556202.5 A0A7P0Z4H7 H0YJ69 ENST00000555249.1 ENST00000356357.9 [O15033-1] G3V5P7 ENST00000555330.5 ENST00000681535.1 A0A7P0T811 ENST00000554070.1 G3V245 ENST00000681099.1 H0YJ67 G3V2B5 G3V506 ENST00000681599.1 [O15033-1] ENST00000553279.5 |